Vivos (RDGL) Interest Coverage Ratio Growth (1y) (2011 - 2021)
Vivos (RDGL) Interest Coverage Ratio Growth (1y) (2011 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | -40.19% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 3.52% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -12.04% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 8.92% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -54.61% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -6.18% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 66.99% |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 12.09% |
| Sep 30, 2021 | -64.72% |
| Jun 30, 2021 | -7,364.89% |
| Mar 31, 2021 | -7,052.94% |
| Dec 31, 2020 | -1,890.65% |
| Sep 30, 2020 | -184.77% |
| Jun 30, 2020 | 39.76% |
| Mar 31, 2020 | 97.51% |
| Dec 31, 2019 | 103.17% |
| Sep 30, 2019 | -179.88% |
| Jun 30, 2019 | -9,049.65% |
| Mar 31, 2019 | -4,341.41% |
| Dec 31, 2018 | -23,333.72% |
| Sep 30, 2018 | -23.52% |
| Jun 30, 2018 | 91.26% |
| Mar 31, 2018 | 34.34% |
| Dec 31, 2017 | -1,515.56% |
| Sep 30, 2017 | 76.50% |
| Jun 30, 2017 | 90.14% |
| Mar 31, 2017 | 95.02% |